General Updates

.~. NEOGEN~ ~~ CHEMICALS LTD. October 31, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Floor 25, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Scrip Code No: 542665 Mumbai – 400 051 Debt Segment Code: 977028 Company Symbol: NEOGEN Sub: Outcome of Board Meeting held on Saturday October 31, 2026. Ref.: Regulation 30 33, 51 and 52 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (“Listing Regulations”). Dear Sir/Madam, With reference to the captioned subject and pursuant to Regulation 30, 33, 51 and 52 read with Schedule III, we wish to inform you that the Board of Directors of Neogen Chemicals Limited (“the Company”) had at its meeting held today i.e., Saturday, October 31, 2026, at 2:31 p.m. and concluded at 7.00 p.m., inter alia considered and approved the following: 1. The Un-audited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026, pursuant to Regulation 33 of the Listing Regulations along with the “Limited Review Report” thereon as provided by the Statutory Auditors of the Company, which has been duly reviewed and recommended by the Audit Committee and the same is enclosed herewith as Annexure I; A copy of the said Financial Results containing disclosures required under Regulations 33, 52, 54 and other provisions of the Listing Regulations, as applicable, together with the Limited Review Reports by M/s. Chandabhoy Jassoobhoy, Chartered Accountants and security cover certificate under Regulation 54(3) and 56(1)(d) of the Listing Regulations is enclosed herewith as Annexure II. 2. Pursuant to Regulation 32 of Listing Regulations, as amended from time to time, Statement of Deviation/ Variation in utilization of funds (“Statement”) for the quarter ended September 30, 2026, which has been duly reviewed by the Audit Committee is enclosed herewith as Annexure III. 3. Increase in threshold for granting loans/ICDs, providing of corporate guarantees/ securities, and making of investments in securities upto Rs. 500 crore under section 186 of the Companies Act, 2013. 4. Material Related Party Transaction(s) (“RPTs”) as mentioned hereunder which may be entered into by and between the Company and Neogen Morita New Materials Limited (“NML”) – a step-down subsidiary of the Company during the period commencing from December 8, 2026 till December 7, 2027, subject to approval of the Members. In terms of Listing Regulations, prior approval of Members by way of an ordinary resolution is required for all material related party transactions and material modifications thereto. The proposed transaction(s) are expected to exceed the prescribed materiality thresholds and accordingly require such approval. All such transaction(s) shall be undertaken in the ordinary course of business and on an arm’s length basis, as reviewed and recommended by the Audit Committee of the Company: Sr. no. Transaction Proposed between the Company and NML: upto Rs. in Crore 1 Granting Corporate Guarantee, Securities or indemnities 500 Registered Office: 1002, Dev Corpora, Cadbury Junction, E: investor@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 .~. NEOGEN~ ~~ CHEMICALS LTD. 5. Material Related Party Transaction(s) (“RPTs”) as mentioned hereunder which may be entered into by and between Neogen Ionics Limited (“NIL”) - a wholly owned subsidiary of the Company and NML during the period commencing from December 8, 2026 till December 7, 2027, subject to approval of the Members. In terms of Listing Regulations, prior approval of Members by way of an ordinary resolution is required for all material related party transactions and material modifications thereto to be executed between the subsidiary Companies of a Listed entity. The proposed transaction(s) are expected to exceed the prescribed materiality thresholds and accordingly require such approval. All such transaction(s) shall be undertaken in the ordinary course of business and on an arm’s length basis, as reviewed and recommended by the Audit Committee of the Company: Sr. No. Transaction Proposed between NIL and NML: Upto Rs. in Crore 1 Granting of Unsecured Loans and advances including inter-corporate deposit(s)/ Credit 200 Facilities. 2 Interest on Inter-corporate deposit(s) /Borrowing of Unsecured Loan(s)/Credit Facilities 24 3 Granting Corporate Guarantee, Securities or indemnities 500 4 Sale of goods including manufactured and traded products, directly or through agent 500 Purchase or supply of any goods or materials like raw materials, WIP and finished goods, 500 5 directly or through agent Leasing of property of any kind & Renting of Factory, Office, Land & Building, Plant and 50 6 Machinery or any other assets Availing or rendering of any services (including all technical, professional, corporate, 50 7 advisory, R&D services, administrative or support services etc.) Infrastructure and resource sharing Arrangements, including cost allocation, recovery and 100 8 reimbursement of shared expenses 9 Purchase, Sale or Transfer of Assets, including Tangible and Intangible Assets 100 6. The pre-mature (Voluntary) early redemption, in full of outstanding 20,000 (Twenty Thousand) fully paid, secured, listed, rated, redeemable, rupee denominated, non-cumulative, non-convertible debentures having a face value of Rs. 1,00,000 each aggregating to INR 200,00,00,000 (Indian Rupees Two Hundred Crores only) (“NCDs”), issued and allotted by the Company on private placement basis on August 12, 2025, bearing ISIN INE136S07013, as per the terms and conditions stated in the General Information Document dated July 28, 2025 read with Key Information Document dated August 11, 2025, the Debenture Trust Deed dated August 06, 2025 and all other Transaction Document(s), inter-alia, between the Company and its Debenture Trustee and subject to receipt of necessary approvals, on such date as may be determined by the Company. A detailed disclosure pursuant to regulation 51(2) of Listing Regulations in this respect alongwith its annexures shall be submitted to the exchanges through a separate intimation. 7. Approved the Postal Ballot Notice to seek approval of the shareholders for the following: Sr. Description of resolution Type of Resolution 1. Approval for Material Related Party Transaction(s) proposed to be entered into by and Ordinary Resolution between the Company and Neogen Morita New Materials Limited, a step-down subsidiary of the Company. Registered Office: 1002, Dev Corpora, Cadbury Junction, E: investor@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 .~. NEOGEN~ ~~ CHEMICALS LTD. 2. Approval for Material Related Party Transaction(s) proposed to be entered into by and Ordinary Resolution between Neogen Ionics Limited- a wholly owned subsidiary of the Company and Neogen Morita New Materials Limited- a step-down subsidiary of the Company. Mr. Devendra Deshpande- Proprietor of M/s. DVD & Associates, Practicing Company Secretaries, Pune, having consented, is appointed to act as Scrutinizer for the purpose of conducting e-voting process in a fair and transparent manner. CALENDAR OF EVENTS FOR THE POSTAL BALLOT PROCESS: Event Date of Events Record date/Cut off Date for identification of voting rights of Thursday, 5 November, 2026 the members Proposed Date for Completion of dispatch of Postal Ballot Friday, 6 November, 2026 Notice (only through electronic mode) Date and time of commencement of remote e-voting Saturday, 7 November, 2026 at 9:00 a.m. IST Date and time of end of remote e-voting Sunday, 6 December, 2026 till 5:00 p.m. IST Last date of Receiving Query Sunday, [Showing first 8,000 characters — download PDF for full document]